Stockreport

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

Prelude Therapeutics Incorporated  (PRLD) 
PDF WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that [Read more]